Dr. Reddy’s Launches Zenatane™

Fri, 03/29/2013 - 7:55am

Dr. Reddy’s Laboratories announced today that it has launched Zenatane™ (Isotretinoin Capsules USP) in 20 mg and 40 mg, a therapeutically equivalent generic version of Accutane® (Isotretinoin Capsules USP) in the US market on March 28, 2013 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Zenatane™ 10 mg, 20 mg and 40 mg.

The total market had U.S. sales of approximately $309 Million for the most recent twelve months ending January 2013 according to IMS Health*.

Dr. Reddy’s Zenatane™ Capsules 10 mg, 20 mg, & 40 mg will be available in boxes of 30 (3 prescription packs of 10 capsules), as unit dose blisters.



Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.